Psoriasis and Nasal congestion
Summary:
Nasal congestion is found among people with Psoriasis, especially for people who are female, 60+ old.
The study analyzes which people have Nasal congestion with Psoriasis. It is created by eHealthMe based on reports of 1,990 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,990 people who have Psoriasis and Nasal Congestion are studied.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,381 drugs and 1,614 conditions by eHealthMe.
What is Nasal congestion?
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels) is found to be associated with 3,066 drugs and 2,266 conditions by eHealthMe.
Number of Nasal congestion in Psoriasis reports submitted per year:

Gender of people who have Psoriasis and experienced Nasal congestion *:
Age of people who have Psoriasis and experienced Nasal congestion *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Nasal congestion?
Check whether Nasal congestion is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Related studies
Treatments, associated drugs and conditions:
- Psoriasis (412,246 reports)
- Nasal congestion (66,863 reports)
COVID vaccines that are related to Nasal congestion:
- Nasal congestion in Moderna COVID Vaccine
- Nasal congestion in Pfizer BioNTech Covid Vaccine
- Nasal congestion in Johnson and Johnson Covid Vaccine
Common drugs associated with Nasal congestion:
- Prednisone: 5,255 reports
- Letairis: 3,800 reports
- Enbrel: 3,479 reports
- Humira: 3,225 reports
- Xolair: 2,887 reports
- Methotrexate: 2,881 reports
- Aspirin: 2,546 reports
- Opsumit: 2,537 reports
- Singulair: 2,533 reports
- Symbicort: 2,197 reports
All the drugs that are associated with Nasal congestion:
- Nasal congestion (3,066 drugs)
Common conditions associated with Nasal congestion:
- Rheumatoid arthritis: 5,822 reports
- Primary pulmonary hypertension: 5,219 reports
- Asthma: 4,871 reports
- Psoriasis: 1,990 reports
- High blood pressure: 1,861 reports
- Crohn's disease: 1,748 reports
All the conditions that are associated with Nasal congestion:
- Nasal congestion (2,266 conditions)
How the study uses the data?
The study is based on Nasal congestion and Psoriasis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Halog and Pruritus Aggravated - 12 seconds ago
- Xeljanz and Blood Brain Barrier Defect - 14 seconds ago
- Benzaclin and Stroke - 19 seconds ago
- Imuran and Renal Failure Acute - 38 seconds ago
- Diphen and Liver Transplant - 40 seconds ago
- Felodipine and Pulmonary Thrombosis - 49 seconds ago
- Calcium and Application Site Discoloration - a minute ago
- Blopress and Kisqali drug interaction - a minute ago
- Aptiom and Lyrica drug interaction - a minute ago
- Candesartan Cilexetil and Oxycodone drug interaction - a minute ago